RET and medullary thyroid gland carcinoma: Moreover, it has been argued that common RET variants might have a modulatory role in MTC outcome rather than alter significantly the risk of disease development, but also in this aspect, conflicting results have been obtained, as in some studies correlations with clinical parameters were observed, while in others, no variants were significantly associated with the clinical outcome of MTC patients [3,13,14].